⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ZBIO News
Zenas BioPharma, Inc. Common Stock
Form 8-K
sec.gov
ZBIO
Zenas BioPharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update
globenewswire.com
ZBIO
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ZBIO
Form 8-K
sec.gov
ZBIO
Zenas BioPharma Announces the Presentation of New Obexelimab Data in IgG4-Related Disease at the 6th International Symposium on IgG4-Related Disease
globenewswire.com
ZBIO
Zenas BioPharma Announces Upcoming Presentations of Orelabrutinib Data in Relapsing Remitting Multiple Sclerosis, Clinical Trial Designs in Progressive Multiple Sclerosis and Other Multiple Sclerosis Portfolio Data at MSToronto2026
globenewswire.com
ZBIO
Zenas BioPharma to Host Virtual R&D Event
globenewswire.com
ZBIO
Zenas BioPharma Announces Upcoming Presentations of Obexelimab Data in IgG4-Related Disease at the IgG4ward! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026
globenewswire.com
ZBIO
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
ZBIO
Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event
globenewswire.com
ZBIO